MorphoSys AG — Board/Management Information 2002

Jun 7, 2002

News Details

Corporate | 7 June 2002 08:08

MorphoSys AG english

MorphoSys Appoints New Supervisory Board Member Corporate-news announcement sent by DGAP. The sender is solely responsible for the contents of this announcement. ——————————————————————————– MorphoSys Appoints New Supervisory Board Member Dr. Daniel Camus of Aventis Pharma AG Appointed MorphoSys AG (Neuer Markt: MOR) announced today that at the company’s annual shareholder meeting yesterday, the Company’s shareholders confirmed the appointment of Dr. Daniel Camus to the MorphoSys supervisory board. Dr. Camus has more than 25 years experience in the pharmaceutical industry acquired in various positions at Hoechst AG, Hoechst Marion Roussel and Aventis Pharma AG as Chief Financial Officer. Mr. Robert Schneider, a member of the MorphoSys supervisory board since 1999, resigned from his office with effect as to the date of yesterday’s General Assembly. In addition to the confirmation of Dr. Camus’ appointment to the supervisory board, all other management proposals of the shareholder assembly agenda were passed with overwhelming majorities at the meeting, which took place in Munich. “We are very pleased that Dr. Camus has joined our board, and thank Mr. Schneider for his support and commitment to MorphoSys during his term with Company”, commented Dr. Simon Moroney, Chief Executive Officer of MorphoSys AG. end of message, (c)DGAP 07.06.2002